Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 149 articles:
HTML format
Text format



Single Articles


    March 2018
  1. DHAR I, Lysne V, Seifert R, Svingen GFT, et al
    Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors.
    Atherosclerosis. 2018;272:175-181.
    PubMed     Text format     Abstract available


  2. WILLIAMS BA, Chagin KM, Bash LD, Boden WE, et al
    External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
    Atherosclerosis. 2018;272:80-86.
    PubMed     Text format     Abstract available


  3. CARLSSON AC, Jansson JH, Soderberg S, Ruge T, et al
    Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Atherosclerosis. 2018;272:41-46.
    PubMed     Text format     Abstract available


    February 2018
  4. YIN H, Pickering JG
    Aortic smooth muscle cells and myocardial infarction: Does the ascending aorta feel a heart attack?
    Atherosclerosis. 2018 Feb 10. pii: S0021-9150(18)30080.
    PubMed     Text format    


    January 2018
  5. MARACLE CX, Agca R, Helder B, Meeuwsen JAL, et al
    Noncanonical NF-kappaB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
    Atherosclerosis. 2018;270:33-41.
    PubMed     Text format     Abstract available


  6. WONGSURAWAT T, Woo CC, Giannakakis A, Lin XY, et al
    Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction.
    Atherosclerosis. 2018 Jan 29. pii: S0021-9150(18)30024.
    PubMed     Text format     Abstract available


    December 2017
  7. HAMAZAKI K, Iso H, Eshak ES, Ikehara S, et al
    Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
    Atherosclerosis. 2017 Dec 8. pii: S0021-9150(17)31423.
    PubMed     Text format     Abstract available


  8. NISHIHIRA K, Shibata Y, Yamashita A, Kuriyama N, et al
    Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction.
    Atherosclerosis. 2017;268:138-144.
    PubMed     Text format     Abstract available


    October 2017
  9. ERCAN E
    Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality.
    Atherosclerosis. 2017 Oct 23. pii: S0021-9150(17)31348.
    PubMed     Text format     Abstract available


    September 2017
  10. CHUNG CM, Lin MS, Chang CH, Cheng HW, et al
    Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
    Atherosclerosis. 2017 Sep 27. pii: S0021-9150(17)31288.
    PubMed     Text format     Abstract available


  11. POKHAREL Y, Sharma PP, Qintar M, Lu Y, et al
    High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
    Atherosclerosis. 2017;266:16-23.
    PubMed     Text format     Abstract available


  12. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study.
    Atherosclerosis. 2017;265:147-154.
    PubMed     Text format     Abstract available


    August 2017
  13. GITT AK, Lautsch D, Ferrieres J, De Ferrari GM, et al
    Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Atherosclerosis. 2017;266:158-166.
    PubMed     Text format     Abstract available


  14. ATTARD R, Dingli P, Doggen CJM, Cassar K, et al
    The independent effect of helicobacter pylori infection and elevated gastrin levels on the risk of myocardial infarction.
    Atherosclerosis. 2017;263:e96-e97.
    PubMed     Text format    


  15. WOO CC, Wongsurawat T, Soong R, Lee CN, et al
    Distinctive pattern of LET-7B and MIR-30B in human aortic smooth muscle cells of myocardial infarction patients.
    Atherosclerosis. 2017;263:e63.
    PubMed     Text format    


  16. KIM TH, Kang K, Kim EM, Park HE, et al
    Mesenchymal stem cells promote the infiltration of myeloid derived suppressor cells in a mouse myocardial infarction model.
    Atherosclerosis. 2017;263:e60.
    PubMed     Text format    


  17. KURDI A, De Meyer GRY, Martinet W
    Everolimus attenuates atherosclerotic plaque progression, intraplaque neovascularization, myocardial infarction and sudden death in a mouse model of advanced atherosclerosis.
    Atherosclerosis. 2017;263:e59.
    PubMed     Text format    


  18. DOULAMIS I, Tzani A, Konstantopoulos P, Gkogkos A, et al
    Sirtuin-1 and MMP-2 levels in patients with advanced coronary artery disease: A combined index for incidence of myocardial infarction.
    Atherosclerosis. 2017;263:e53.
    PubMed     Text format    


  19. RYAZANKINA N, Manchurov V, Vasilieva E, Shpektor A, et al
    Improved in-hospital clinical outcomes in patients with acute ST-elevation myocardial infarction undergoing remote ischemic preconditioning before primary percutaneous coronary intervention.
    Atherosclerosis. 2017;263:e49-e50.
    PubMed     Text format    


  20. MARINKOVIC G, Winkler L, Kefene L, Nilsson J, et al
    The alarmin complex S100A8/9 as a potential therapeutic target after myocardial infarction.
    Atherosclerosis. 2017;263:e48-e49.
    PubMed     Text format    


  21. PFETSCH V, Sanin V, Jaensch A, Dallmeier D, et al
    Increased concentrations of soluble ST2 independently predict cardiac and total mortality but not non-fatal cardiovascular events in stable coronary heart disease patients.
    Atherosclerosis. 2017;263:e46-e47.
    PubMed     Text format    


  22. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
    Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IGG-related coronary heart disease prediction in the general population.
    Atherosclerosis. 2017;263:e45.
    PubMed     Text format    


  23. PECHERINA T, Kashtalap V, Barbarash O
    Effects of statins on inflammatory markers and matrix metalloproteinases in patients with ST-segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e45-e46.
    PubMed     Text format    


  24. BOUZID K, Ben Ahmed H, Boussaid H, Kamoun M, et al
    Relationship between galectin-3 levels in ST elevation myocardial infarction and the burden of atherosclerosis.
    Atherosclerosis. 2017;263:e275.
    PubMed     Text format    


  25. NIZOMOV A, Kenjaev S
    Effect of high-dose atorvastatin on lipid spectrum and inflammation in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245-e246.
    PubMed     Text format    


  26. AZIZ N, Sirojiddin K, Majid K
    Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245.
    PubMed     Text format    


  27. GRAESDAL A, Dybvig A
    Lipoprotein apheresis as a treatment modality for familial combined hyperlipidemia (FCH) with non-alcoholic fatty liver disease (NAFLD) and coronary heart disease: a casuistic approach.
    Atherosclerosis. 2017;263:e243-e244.
    PubMed     Text format    


  28. BATURINA O, Mironova O
    Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
    Atherosclerosis. 2017;263:e227-e228.
    PubMed     Text format    


  29. REVNIC CR, Revnic F, Pena C, Nica AS, et al
    Biochemical studies of atherogenic potential of serum from patients with unstable angina coronary atherosclerosis.
    Atherosclerosis. 2017;263:e219-e220.
    PubMed     Text format    


  30. QAYYUM F, Lauridsen B, Frikke-Schmidt R, Nordestgaard B, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Atherosclerosis. 2017;263:e21.
    PubMed     Text format    


  31. PAPADOPOULOS D, Grassos H, Sanidas E, Barbetseas J, et al
    Triglyceride blood levels and metalloproteinases activity in acute myocardial infarction patients.
    Atherosclerosis. 2017;263:e203.
    PubMed     Text format    


  32. FEDOROVA N, Kashtalap V, Barbarash O
    Galectin-3 levels in patients with ST segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e199.
    PubMed     Text format    


  33. PECHERINA T, Kashtalap V, Barbarash O, Zhuravleva E, et al
    The value of matrix metalloproteinases in coronary atherosclerosis progression in patients after ST-segment elevation myocardial infarction in one year.
    Atherosclerosis. 2017;263:e198.
    PubMed     Text format    


  34. ZIVOTIC I, Zivkovic M, Djuric T, Stankovic A, et al
    Rs10757278 from 9p21 is associated with ST-elevated myocardial infarction in females in population of Serbia.
    Atherosclerosis. 2017;263:e188.
    PubMed     Text format    


  35. FARES AL, Hussein El Bacha AA, Souza CS, Garcia De Carvalho JA, et al
    High prevalence of familial hypercholesterolemia in patients with coronary heart disease at a Brazilian quaternary healthcare center.
    Atherosclerosis. 2017;263:e181-e183.
    PubMed     Text format    


  36. DJORDJEVIC A, Zivkovic M, Dekleva M, Markovic-Nikolic N, et al
    SNPS in the vicinity of LGALS-3 locus and different shape-types of heart remodeling after the first myocardial infarction: Preliminary results.
    Atherosclerosis. 2017;263:e180.
    PubMed     Text format    


  37. NUSSBAUMEROVA B, Rosolova H, Mayer O Jr, Filipovsky J, et al
    Residual cardiovascular risk in patients with stable coronary heart disease over the last 16 years (Czech part of the EUROASPIRE I-IV surveys).
    Atherosclerosis. 2017;263:e177.
    PubMed     Text format    


  38. KASHTALAP V, Barbarash O, Gorbunova E, Sedyh D, et al
    Psychophysiological personality characteristics of patients with recurrent myocardial infarction.
    Atherosclerosis. 2017;263:e174.
    PubMed     Text format    


  39. IGNATEVA O, Berkovich O, Volkova E, Moroshkina N, et al
    S19W polymorphism of apo AV is an independent risk factor for myocardial infarction among young men.
    Atherosclerosis. 2017;263:e173-e174.
    PubMed     Text format    


  40. DIAZ-PEROMINGO JA, Macia-Rodriguez C, Alende-Castro V, Paez-Guillan E, et al
    Comorbidity and sex differences among patients with ischemic heart disease currently smokers.
    Atherosclerosis. 2017;263:e172.
    PubMed     Text format    


  41. KECHIDA M, Jomaa W, Hamda KB, Klii R, et al
    Myocardial infarction as a first symptom of activated protein C resistance associated to hyperhomocyteinemia.
    Atherosclerosis. 2017;263:e162.
    PubMed     Text format    


  42. NIZOMOV A, Kenjaev M, Kenjaev S, Kenjaev S, et al
    The relationship between the parameters of longitudinal systolic function and left ventricular remodeling in patients with acute myocardial infarction.
    Atherosclerosis. 2017;263:e159.
    PubMed     Text format    


  43. HONG TJ, Lee HW, Choi JH, Choi JC, et al
    Comparison of long term clinical outcomes between bare metal stent versus different types of drug eluting stents for treatment of acute myocardial infarction.
    Atherosclerosis. 2017;263:e155-e156.
    PubMed     Text format    


  44. SHALAEVA A, Dadabaeva N
    Compliance initiatives in management of patients with coronary artery disease after acute myocardial infarction.
    Atherosclerosis. 2017;263:e152-e153.
    PubMed     Text format    


  45. SHAH N, Meira L, Elliott R, Bordin D, et al
    DNA repair measuring DNA ligase activity in non ST-elevation myocardial infarction determines atherosclerotic plaque instability.
    Atherosclerosis. 2017;263:e143.
    PubMed     Text format    


  46. SHAH N, Meira L, Forrer-Charlier C, Mahmoudi M, et al
    Up-regulation of base excision repair gene 8-oxoguanine glycosylase 1 expression in non ST-elevation myocardial infarction and correlation with atherosclerotic fibrous cap thickness.
    Atherosclerosis. 2017;263:e142-e143.
    PubMed     Text format    


  47. ROMANOVA V
    Condition of adhesive endothelial function in coronary heart disease patients.
    Atherosclerosis. 2017;263:e141.
    PubMed     Text format    


  48. DUMITRIU IE, Bulenkamp J, Chhetri I
    Homeostatic cytokines interleukin-7 (IL-7) and IL-15 drive the expansion and activation of CD4+CD28null t cells in patients with myocardial infarction.
    Atherosclerosis. 2017;263:e14-e15.
    PubMed     Text format    


  49. NIZOMOV A, Kenjaev S, Kenjaev M, Mukhamedova M, et al
    Dynamics of indicators of longitudinal left ventricular systolic function in patients with acute myocardial infarction during stress echocardiography with dobutamine.
    Atherosclerosis. 2017;263:e122.
    PubMed     Text format    


  50. MUSIKHINA N, Petelina T, Gapon L, Emeneva I, et al
    Peculiarity of vascular inflammatory response in patients with unstable angina.
    Atherosclerosis. 2017;263:e118.
    PubMed     Text format    


  51. VERWEIJ S, Delewi R, Stiekema L, Versloot M, et al
    Prolonged inflammatory state after myocardial infarction.
    Atherosclerosis. 2017;263:e117-e118.
    PubMed     Text format    


  52. KUMAR V
    Demonstrating the decline in coronary heart disease mortality in the Central Delhi, India between 2010 to 2015.
    Atherosclerosis. 2017;263:e110.
    PubMed     Text format    


  53. DE GONZALO CALVO D, Sanchez Vega J, Vilades D, Nasarre L, et al
    Diagnostic value of circulating miRNAs: Association with the presence and extension of coronary atherosclerosis in patients with suspected ischemic heart disease.
    Atherosclerosis. 2017;263:e106.
    PubMed     Text format    


    July 2017
  54. AGARWALA A, Pokharel Y, Saeed A, Sun W, et al
    The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Atherosclerosis. 2017;262:131-137.
    PubMed     Text format     Abstract available


  55. HOLMLUND A, Lampa E, Lind L
    Oral health and cardiovascular disease risk in a cohort of periodontitis patients.
    Atherosclerosis. 2017;262:101-106.
    PubMed     Text format     Abstract available


  56. CHUNG RWS, Leanderson P, Lundberg AK, Jonasson L, et al
    Lutein exerts anti-inflammatory effects in patients with coronary artery disease.
    Atherosclerosis. 2017;262:87-93.
    PubMed     Text format     Abstract available


  57. TOUTOUZAS K, Benetos G, Koutagiar I, Barampoutis N, et al
    Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
    Atherosclerosis. 2017;262:25-30.
    PubMed     Text format     Abstract available


  58. ZHANG Q, Wang A, Zhang S, Li N, et al
    Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
    Atherosclerosis. 2017;262:1-7.
    PubMed     Text format     Abstract available


  59. CHO I, O Hartaigh B, Gransar H, Valenti V, et al
    Prognostic implications of coronary artery calcium in the absence of coronary artery luminal narrowing.
    Atherosclerosis. 2017;262:185-190.
    PubMed     Text format     Abstract available


    June 2017
  60. MOXON JV, Jones RE, Wong G, Weir JM, et al
    Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations.
    Atherosclerosis. 2017;263:301-308.
    PubMed     Text format     Abstract available


  61. VONGPROMEK R, Bos S, Ten Kate GR, Bujo H, et al
    Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
    Atherosclerosis. 2017 Jun 9. pii: S0021-9150(17)30268.
    PubMed     Text format     Abstract available


  62. HUANG F, Liu Y, Yang X, Che D, et al
    Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
    Atherosclerosis. 2017;263:184-191.
    PubMed     Text format     Abstract available


  63. FAIROOZY RH, Cooper J, White J, Giambartolomei C, et al
    Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
    Atherosclerosis. 2017;261:60-68.
    PubMed     Text format     Abstract available


  64. WANG A, Kwee LC, Grass E, Neely ML, et al
    Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
    Atherosclerosis. 2017;261:19-25.
    PubMed     Text format     Abstract available


  65. NAKAJIMA S, Ito H, Mitsuhashi T, Kubo Y, et al
    Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography.
    Atherosclerosis. 2017;261:138-143.
    PubMed     Text format     Abstract available


  66. TADA H, Kawashiri MA, Sakata K, Yoneda T, et al
    Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.
    Atherosclerosis. 2017;261:111-116.
    PubMed     Text format     Abstract available


    May 2017
  67. ERIKSSON OSTMAN M, Calais F, Rosenblad A, Frobert O, et al
    Prognostic impact of subclinical or manifest extracoronary artery diseases after acute myocardial infarction.
    Atherosclerosis. 2017;263:53-59.
    PubMed     Text format     Abstract available


  68. FERNANDEZ-SANLES A, Sayols-Baixeras S, Subirana I, Degano IR, et al
    Association between DNA methylation and coronary heart disease or other atherosclerotic events: A systematic review.
    Atherosclerosis. 2017 May 18. pii: S0021-9150(17)30225.
    PubMed     Text format     Abstract available


  69. HARRIS WS, Del Gobbo L, Tintle NL
    The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies.
    Atherosclerosis. 2017;262:51-54.
    PubMed     Text format     Abstract available


  70. NOLLET E, Hoymans VY, Rodrigus IR, De Bock D, et al
    Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease.
    Atherosclerosis. 2017;260:138-146.
    PubMed     Text format     Abstract available


  71. GLEISSNER CA, Erbel C, Linden F, Domschke G, et al
    Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
    Atherosclerosis. 2017;260:121-129.
    PubMed     Text format     Abstract available


  72. VERDOIA M, Nardin M, Rolla R, Marino P, et al
    Immature platelet fraction and the extent of coronary artery disease: A single centre study.
    Atherosclerosis. 2017;260:110-115.
    PubMed     Text format     Abstract available


  73. PANH L, Ruidavets JB, Rousseau H, Petermann A, et al
    Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients.
    Atherosclerosis. 2017;260:81-86.
    PubMed     Text format     Abstract available


  74. BASKARAN L, O Hartaigh B, Schulman-Marcus J, Gransar H, et al
    Dense calcium and lesion-specific ischemia: A comparison of CCTA with fractional flow reserve.
    Atherosclerosis. 2017;260:163-168.
    PubMed     Text format     Abstract available


    April 2017
  75. ALBREKTSEN G, Heuch I, Lochen ML, Thelle DS, et al
    Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromso Study 1979-2012.
    Atherosclerosis. 2017;261:52-59.
    PubMed     Text format     Abstract available


  76. KITAHARA H, Waseda K, Sakamoto K, Yamada R, et al
    Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
    Atherosclerosis. 2017;259:68-74.
    PubMed     Text format     Abstract available


    March 2017
  77. LI S, Wu NQ, Zhu CG, Zhang Y, et al
    Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Atherosclerosis. 2017;260:67-74.
    PubMed     Text format     Abstract available


  78. MATSUNAGA M, Yatsuya H, Iso H, Yamashita K, et al
    Similarities and differences between coronary heart disease and stroke in the associations with cardiovascular risk factors: The Japan Collaborative Cohort Study.
    Atherosclerosis. 2017 Mar 6. pii: S0021-9150(17)30093.
    PubMed     Text format     Abstract available


  79. KITAGAWA K, Amano T, Uetani T, Ishii H, et al
    Association between plaque characteristics and the amount of debris captured by a filter-type distal protection device in patients with acute coronary syndrome.
    Atherosclerosis. 2017;258:72-78.
    PubMed     Text format     Abstract available


  80. KWON CH, Kang JG, Lee HJ, Kim NH, et al
    Absence of association between gallstone and coronary artery calcification.
    Atherosclerosis. 2017;258:51-55.
    PubMed     Text format     Abstract available


  81. RIZVI A, Hartaigh BO, Danad I, Han D, et al
    Diffuse coronary artery disease among other atherosclerotic plaque characteristics by coronary computed tomography angiography for predicting coronary vessel-specific ischemia by fractional flow reserve.
    Atherosclerosis. 2017;258:145-151.
    PubMed     Text format     Abstract available


  82. ABD-ELMONIEM KZ, Ramos N, Yazdani SK, Ghanem AM, et al
    Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.
    Atherosclerosis. 2017;258:20-25.
    PubMed     Text format     Abstract available


  83. SHAHID SU, Shabana, Cooper JA, Beaney KE, et al
    Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants.
    Atherosclerosis. 2017;258:1-7.
    PubMed     Text format     Abstract available


  84. CAMPOS AM, Moura FA, Santos SN, Freitas WM, et al
    Sarcopenia, but not excess weight or increased caloric intake, is associated with coronary subclinical atherosclerosis in the very elderly.
    Atherosclerosis. 2017;258:138-144.
    PubMed     Text format     Abstract available


  85. MADSEN DM, Diederichsen ACP, Hosbond SE, Gerke O, et al
    Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Atherosclerosis. 2017;258:131-137.
    PubMed     Text format     Abstract available


    February 2017
  86. LIU LP, Cheng K, Ning MA, Li HH, et al
    Association between peripheral blood cells mitochondrial DNA content and severity of coronary heart disease.
    Atherosclerosis. 2017 Feb 20. pii: S0021-9150(17)30065.
    PubMed     Text format     Abstract available


  87. CHRISTIANSEN MK, Nyegaard M, Pedersen LN, Larsen SB, et al
    A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering.
    Atherosclerosis. 2017;257:172-178.
    PubMed     Text format     Abstract available


  88. OSAWA K, Nakanishi R, Budoff MJ
    Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease?
    Atherosclerosis. 2017;257:279-287.
    PubMed     Text format     Abstract available


  89. LIN JF, Wu S, Juang JJ, Chiang FT, et al
    IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
    Atherosclerosis. 2017;257:71-77.
    PubMed     Text format     Abstract available


  90. DE VRIES MA, Trompet S, Mooijaart SP, Smit RA, et al
    Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.
    Atherosclerosis. 2017;257:16-21.
    PubMed     Text format     Abstract available


  91. KIM J, Budoff MJ, Nasir K, Wong ND, et al
    Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2017;257:1-8.
    PubMed     Text format     Abstract available


  92. LEE EM, Choi MH, Seo HS, Kim HK, et al
    Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
    Atherosclerosis. 2017;257:195-200.
    PubMed     Text format     Abstract available


  93. CHEEZUM MK, Kim A, Bittencourt MS, Kassop D, et al
    Association of tobacco use and cessation with coronary atherosclerosis.
    Atherosclerosis. 2017;257:201-207.
    PubMed     Text format     Abstract available


    January 2017
  94. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
    An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
    Atherosclerosis. 2017;258:40-50.
    PubMed     Text format     Abstract available


  95. WIDHALM K, Benke IM, Fritz M, Geiger H, et al
    Homozygous familial hypercholesterolemia: Summarized case reports.
    Atherosclerosis. 2017;257:86-89.
    PubMed     Text format     Abstract available


  96. BRUCKERT E, Kalmykova O, Bittar R, Carreau V, et al
    Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
    Atherosclerosis. 2017;257:130-137.
    PubMed     Text format     Abstract available


  97. BOS S, Duvekot MH, Ten Kate GR, Verhoeven AJ, et al
    Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
    Atherosclerosis. 2017;256:62-66.
    PubMed     Text format     Abstract available


  98. NONIN S, Iwata S, Sugioka K, Fujita S, et al
    Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
    Atherosclerosis. 2017;256:29-34.
    PubMed     Text format     Abstract available


    December 2016
  99. LEE DH, Chun EJ, Hur JH, Min SH, et al
    Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
    Atherosclerosis. 2016;257:47-54.
    PubMed     Text format     Abstract available


  100. RASMUSSEN KL
    Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.
    Atherosclerosis. 2016;255:145-155.
    PubMed     Text format     Abstract available


    November 2016
  101. SCICALI R, Giral P, Gallo A, Di Pino A, et al
    HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
    Atherosclerosis. 2016;255:102-108.
    PubMed     Text format     Abstract available


  102. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
    Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
    Atherosclerosis. 2016;255:73-79.
    PubMed     Text format     Abstract available


    October 2016
  103. LU Y, Cheng Z, Zhao Y, Chang X, et al
    Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
    Atherosclerosis. 2016;254:215-227.
    PubMed     Text format     Abstract available


  104. OGURA M, Makino H, Kamiya C, Yoshimatsu J, et al
    Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion.
    Atherosclerosis. 2016;254:179-183.
    PubMed     Text format     Abstract available


    September 2016
  105. GUO XY, Li N, Du X, Bai R, et al
    Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.
    Atherosclerosis. 2016;254:1-7.
    PubMed     Text format     Abstract available


  106. ELAJAMI TK, Giuseffi J, Avila MD, Hovnanians N, et al
    Parity, coronary heart disease and mortality in the old order Amish.
    Atherosclerosis. 2016;254:14-19.
    PubMed     Text format     Abstract available


  107. MANGILI LC, Mangili OC, Bittencourt MS, Miname MH, et al
    Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.
    Atherosclerosis. 2016;254:73-77.
    PubMed     Text format     Abstract available


  108. SANTOS-GALLEGO CG, Wallert M, Peter K
    Myocardial infarction caused by surgery: Blame inflammation not the surgeon.
    Atherosclerosis. 2016 Sep 1. pii: S0021-9150(16)31312.
    PubMed     Text format    


    August 2016
  109. ALONSO R, Mata P, Muniz O, Fuentes-Jimenez F, et al
    PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
    Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31306.
    PubMed     Text format     Abstract available


  110. ZENG L, Dang TA, Schunkert H
    Genetics links between transforming growth factor beta pathway and coronary disease.
    Atherosclerosis. 2016 Aug 25. pii: S0021-9150(16)31290.
    PubMed     Text format     Abstract available


  111. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
    Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
    Atherosclerosis. 2016;253:1-6.
    PubMed     Text format     Abstract available


    July 2016
  112. WATTS GF, Pang J, Chan DC, Brunt JN, et al
    Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
    Atherosclerosis. 2016;252:82-87.
    PubMed     Text format     Abstract available


  113. VISSERS LE, Waller MA, van der Schouw YT, Hebert JR, et al
    The relationship between the dietary inflammatory index and risk of total cardiovascular disease, ischemic heart disease and cerebrovascular disease: Findings from an Australian population-based prospective cohort study of women.
    Atherosclerosis. 2016 Jul 30. pii: S0021-9150(16)31230.
    PubMed     Text format     Abstract available


  114. YUBERO-SERRANO EM, Delgado-Lista J, Alcala-Diaz JF, Garcia-Rios A, et al
    A dysregulation of glucose metabolism control is associated with carotid atherosclerosis in patients with coronary heart disease (CORDIOPREV-DIAB study).
    Atherosclerosis. 2016 Jul 16. pii: S0021-9150(16)31204.
    PubMed     Text format     Abstract available


    June 2016
  115. DISTELMAIER K, Schrutka L, Wurm R, Seidl V, et al
    Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.
    Atherosclerosis. 2016 Jun 24. pii: S0021-9150(16)30282.
    PubMed     Text format     Abstract available


  116. LOUWE MC, Lammers B, Frias MA, Foks AC, et al
    Abca1 deficiency protects the heart against myocardial infarction-induced injury.
    Atherosclerosis. 2016;251:159-163.
    PubMed     Text format     Abstract available


  117. MENZEL J, di Giuseppe R, Biemann R, Wittenbecher C, et al
    Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.
    Atherosclerosis. 2016 Jun 2. pii: S0021-9150(16)30243.
    PubMed     Text format     Abstract available


    May 2016
  118. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
    Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
    Atherosclerosis. 2016;250:114-121.
    PubMed     Text format     Abstract available


  119. MENEGAUT L, Masson D, Abello N, Denimal D, et al
    Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
    PubMed     Text format     Abstract available


  120. MANTAS D, Markopoulos C
    Screening mammography: Usefulness beyond early detection of breast cancer.
    Atherosclerosis. 2016;248:1.
    PubMed     Text format    


  121. PARK SJ, Yang HM, Seo KW, Choi SY, et al
    The relationship between coronary atherosclerosis and body fat distribution measured using dual energy X-ray absorptiometry.
    Atherosclerosis. 2016;248:190-5.
    PubMed     Text format     Abstract available


  122. YONGSAKULCHAI P, Settasatian C, Settasatian N, Komanasin N, et al
    Association of combined genetic variations in PPARgamma, PGC-1alpha, and LXRalpha with coronary artery disease and severity in Thai population.
    Atherosclerosis. 2016;248:140-8.
    PubMed     Text format     Abstract available


  123. CHENG JM, Oemrawsingh RM, Garcia-Garcia HM, Boersma E, et al
    PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
    Atherosclerosis. 2016;248:117-22.
    PubMed     Text format     Abstract available


  124. GLEISSNER CA
    Translational atherosclerosis research: From experimental models to coronary artery disease in humans.
    Atherosclerosis. 2016;248:110-6.
    PubMed     Text format     Abstract available


  125. CAHILL PA, Redmond EM
    Vascular endothelium - Gatekeeper of vessel health.
    Atherosclerosis. 2016;248:97-109.
    PubMed     Text format     Abstract available


    April 2016
  126. MIRANDA CH, de Carvalho Borges M, Schmidt A, Marin-Neto JA, et al
    Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome.
    Atherosclerosis. 2016;247:184-8.
    PubMed     Text format     Abstract available


  127. OEMRAWSINGH RM, Cheng JM, Garcia-Garcia HM, Kardys I, et al
    High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study.
    Atherosclerosis. 2016;247:135-41.
    PubMed     Text format     Abstract available


  128. DAI J, Tian J, Hou J, Xing L, et al
    Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study.
    Atherosclerosis. 2016;247:111-7.
    PubMed     Text format     Abstract available


  129. NAITO R, Miyauchi K, Konishi H, Tsuboi S, et al
    Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008.
    Atherosclerosis. 2016;247:105-10.
    PubMed     Text format     Abstract available


  130. SKAGEN K, Troseid M, Ueland T, Holm S, et al
    The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Atherosclerosis. 2016;247:64-9.
    PubMed     Text format     Abstract available


  131. CAVALCANTE R, Bittencourt MS, Pinheiro TL, Falcao BA, et al
    Validation of coronary computed tomography angiography scores for non-invasive assessment of atherosclerotic burden through a comparison with multivessel intravascular ultrasound.
    Atherosclerosis. 2016;247:21-7.
    PubMed     Text format     Abstract available


    February 2016
  132. MULDERS TA, Taraboanta C, Franken LC, van Heel E, et al
    Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease.
    Atherosclerosis. 2016;245:155-60.
    PubMed     Text format     Abstract available


  133. GUO L, Wang L, Li H, Yang X, et al
    Down regulation of GALNT3 contributes to endothelial cell injury via activation of p38 MAPK signaling pathway.
    Atherosclerosis. 2016;245:94-100.
    PubMed     Text format     Abstract available


  134. OLSON F, Engborg J, Gronhoj MH, Sand NP, et al
    Association between high-sensitive troponin I and coronary artery calcification in a Danish general population.
    Atherosclerosis. 2016;245:88-93.
    PubMed     Text format     Abstract available


  135. SUH B, Park S, Shin DW, Ahn H, et al
    Early repolarization is associated with significant coronary artery stenosis in asymptomatic adults.
    Atherosclerosis. 2016;245:50-3.
    PubMed     Text format     Abstract available


  136. VAGNARELLI F, Corsini A, Lorenzini M, Ortolani P, et al
    Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes.
    Atherosclerosis. 2016;245:43-9.
    PubMed     Text format     Abstract available


  137. CRAIEM D, Chironi DG, Casciaro ME, Sirieix ME, et al
    Association of thoracic aorta calcium and non cardiac vascular events in cardiac disease-free individuals.
    Atherosclerosis. 2016;245:22-7.
    PubMed     Text format     Abstract available


    January 2016
  138. OGITA M, Miyauchi K, Kasai T, Tsuboi S, et al
    Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Atherosclerosis. 2016;244:216-21.
    PubMed     Text format     Abstract available


  139. SAELY CH, Leiherer A, Muendlein A, Vonbank A, et al
    High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.
    Atherosclerosis. 2016;244:38-43.
    PubMed     Text format     Abstract available


    December 2015
  140. RHEE EJ, Kim JH, Park HJ, Park SE, et al
    Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study.
    Atherosclerosis. 2015;245:132-138.
    PubMed     Text format     Abstract available


    November 2015
  141. CHEN X, Bakillah A, Zhou L, Pan X, et al
    Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease.
    Atherosclerosis. 2015;245:12-21.
    PubMed     Text format     Abstract available


    October 2015
  142. PURI R, Nissen SE, Menon V, Shao M, et al
    Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
    Atherosclerosis. 2015;243:553-559.
    PubMed     Text format     Abstract available


    September 2015
  143. MOURA FA, Figueiredo VN, Teles BS, Barbosa MA, et al
    Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
    Atherosclerosis. 2015;243:124-130.
    PubMed     Text format     Abstract available


  144. SHIN DG, Han SM, Kim DI, Rhee MY, et al
    Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
    Atherosclerosis. 2015;243:53-58.
    PubMed     Text format     Abstract available


  145. TZIOMALOS K, Giampatzis V, Bouziana SD, Spanou M, et al
    Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.
    Atherosclerosis. 2015;243:65-70.
    PubMed     Text format     Abstract available


  146. BARKAS F, Elisaf M, Milionis H
    Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
    Atherosclerosis. 2015;243:60-64.
    PubMed     Text format     Abstract available


    August 2015
  147. YU HH, Chen PC, Yang YH, Wang LC, et al
    Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
    Atherosclerosis. 2015;243:11-18.
    PubMed     Text format     Abstract available


    July 2015
  148. PRUDENTE S, Bailetti D, Mendonca C, Mannino GC, et al
    Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.
    Atherosclerosis. 2015;242:334-339.
    PubMed     Text format     Abstract available


  149. TANAKA A, Ishii H, Oshima H, Narita Y, et al
    Inverse association between diabetes and aortic dilatation in patients with advanced coronary artery disease.
    Atherosclerosis. 2015;242:123-127.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: